Kamil Bugała
5 Papers
2 Citations
Kamil Bugała is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
Hanna Dziedzic-Oleksy,Adam Mazurek,Kamil Bugała,Carlo Perricone,Leszek Drabik,Wojciech Płazak +5 more
TL;DR: PWV was associated with the presence of coronary atherosclerotic lesions in MDCT and arterial stiffness was higher in patients with markers of endothelial dysfunction and a prothrombotic state, suggesting their contribution to the early stages of arterial remodelling in SLE.
Apical hypertrophic cardiomyopathy in an adult (RCD code: III-2A)
TL;DR: A long follow-up period of a patient with AHC is presented and the management of patients with HCM is directed at reducing left ventricle outflow tract narrowing, decreasing of intraventricular gradient, heart failure treatment and prevention of sudden cardiac death.
Echocardiographic correlates of dyspnoea during acute decompensated heart failure treatment
TL;DR: Bugsała et al. as mentioned in this paper studied the echocardiographic correlates of dyspnoea during acute decompensated heart failure treatment and found that the dyspoea was associated with the use of heart failure drugs.
Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients
Kamil Bugała,Adam Mazurek,Krzysztof Gryga,Monika Komar,Grzegorz Kopeć,Jacek Musiał,Piotr Podolec,Carlo Perricone,Wojciech Płazak +8 more
TL;DR: In one third of young patients with stable SLE, signs of endothelial activation/damage were found, as shown by elevated plasma ICAM-1 or vWF, and increased prothrombotic tendency manifested by elevated TAT was found in one fifth of the patients.
Influence of statin therapy on antiphospholipid antibodies and endothelial dysfunction in young patients with coronary artery disease and systemic lupus erythematosus
Adam Mazurek,Krzysztof Gryga,Kamil Bugała,Teresa Iwaniec,Jacek Musiał,Piotr Podolec,Wojciech Płazak +6 more
TL;DR: Investigation of the influence of statin treatment on aPL antibody levels and selected endothelial dysfunction markers in CAD and SLE patients found IgM and IgG class aβ2GPI levels are higher in CAD than in SLE, whereas IgGclass aCL levels are lower.